Onconetix, Inc. Impairment of Intangible Assets, Finite-lived
Onconetix, Inc. (ONCO) reported Impairment of Intangible Assets, Finite-lived of $356.64 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-06-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2025-11-13
- Onconetix, Inc. impairment of intangible assets, finite-lived for the quarter ending 2024-12-31 was $0.00.
- Onconetix, Inc. impairment of intangible assets, finite-lived for the quarter ending 2024-09-30 was $0.00.
- Onconetix, Inc. impairment of intangible assets, finite-lived for the quarter ending 2024-06-30 was -$1.92M.
- Onconetix, Inc. impairment of intangible assets, finite-lived for the quarter ending 2024-03-31 was $2.28M.
- Onconetix, Inc. impairment of intangible assets, finite-lived for fiscal 2024 was $356.64K.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | -$1.92M derived: sum of 3 quarters · filed 2025-11-13 | $356.64K 10-K · filed 2025-06-02 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.92M derived: sum of 2 quarters · filed 2025-11-13 | $356.64K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $356.64K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $2.28M 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |